E
Sell
10/2/2024Upgraded
FibroBiologics, Inc. (FBLG) was upgraded to E+ from E on 10/2/2024 due to an increase in the growth index, solvency index and valuation index. Earnings per share increased from -$0.2717 to $0.0274, operating cash flow increased 54.46% from -$4.28M to -$1.95M, and debt to equity declined from -0.22 to -0.28.
E
Sell
7/1/2024Upgraded
FibroBiologics, Inc. (FBLG) was upgraded to E from E- on 7/1/2024 due to a noticeable increase in the valuation index, efficiency index and growth index. Earnings per share increased from -$0.3442 to -$0.2717, and net income increased 12.94% from -$9.72M to -$8.46M.
E
Sell
4/25/2024None
FibroBiologics, Inc. (FBLG) was downgraded to E- from U on 04/25/2024.
